This new book edited by rare disease experts Anthony Hall and Nicolas Sireau provides a collection of chapters by world leaders in the field of orphan diseases and drugs in order to help patient groups grow fast and sustainably. As a practical, hands-on guide for research and drug development, it provides tools and advice on topics such as: - How to set up and manage a patient group: US and UK perspectives. - How to build an international research consortium. - How to promote basic research. - How to engage with academia for drug discovery. - How to engage with industry. - How to set up a centre of excellence. - New funding strategies for clinical research. - Crowdfunding for rare diseases. - Practical thinking to win bids. - Orphan drug legislation and adaptive licensing. - Early interaction with regulators and parallel scientific advice with health technology assessors. - How to navigate the regulatory process. - Empowering children to become involved in the research agenda. - Natural history studies. - Clinical efficacy measures and surrogate endpoints. - Statistical considerations. - Setting up and running a clinical trial. - Patient registries. - How to interact with government and lobby for change to the clinical trials system. - Patent protection and ownership of patents. - Engaging patients and carers online for clinical trials. If you are involved in patient groups or rare diseases in any way, then this book will provide valuable reading. All royalties from sales of this book are being donated to the charity Findacure, which provides support to rare disease patient groups.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: AwesomeBooks, Wallingford, Vereinigtes Königreich
Paperback. Zustand: Very Good. The Patient Group Handbook: A Practical Guide for Research and Drug Development This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. Bestandsnummer des Verkäufers 7719-9781523320103
Anzahl: 1 verfügbar
Anbieter: Bahamut Media, Reading, Vereinigtes Königreich
Paperback. Zustand: Very Good. This book is in very good condition and will be shipped within 24 hours of ordering. The cover may have some limited signs of wear but the pages are clean, intact and the spine remains undamaged. This book has clearly been well maintained and looked after thus far. Money back guarantee if you are not satisfied. See all our books here, order more than 1 book and get discounted shipping. Bestandsnummer des Verkäufers 6545-9781523320103
Anzahl: 1 verfügbar
Anbieter: California Books, Miami, FL, USA
Zustand: New. Print on Demand. Bestandsnummer des Verkäufers I-9781523320103
Anzahl: Mehr als 20 verfügbar
Anbieter: THE SAINT BOOKSTORE, Southport, Vereinigtes Königreich
Paperback / softback. Zustand: New. This item is printed on demand. New copy - Usually dispatched within 5-9 working days. Bestandsnummer des Verkäufers C9781523320103
Anzahl: Mehr als 20 verfügbar
Anbieter: CitiRetail, Stevenage, Vereinigtes Königreich
Paperback. Zustand: new. Paperback. This new book edited by rare disease experts Anthony Hall and Nicolas Sireau provides a collection of chapters by world leaders in the field of orphan diseases and drugs in order to help patient groups grow fast and sustainably. As a practical, hands-on guide for research and drug development, it provides tools and advice on topics such as: - How to set up and manage a patient group: US and UK perspectives. - How to build an international research consortium. - How to promote basic research. - How to engage with academia for drug discovery. - How to engage with industry. - How to set up a centre of excellence. - New funding strategies for clinical research. - Crowdfunding for rare diseases. - Practical thinking to win bids. - Orphan drug legislation and adaptive licensing. - Early interaction with regulators and parallel scientific advice with health technology assessors. - How to navigate the regulatory process. - Empowering children to become involved in the research agenda. - Natural history studies. - Clinical efficacy measures and surrogate endpoints. - Statistical considerations. - Setting up and running a clinical trial. - Patient registries. - How to interact with government and lobby for change to the clinical trials system. - Patent protection and ownership of patents. - Engaging patients and carers online for clinical trials. If you are involved in patient groups or rare diseases in any way, then this book will provide valuable reading. All royalties from sales of this book are being donated to the charity Findacure, which provides support to rare disease patient groups. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Bestandsnummer des Verkäufers 9781523320103
Anzahl: 1 verfügbar